Trials / Completed
CompletedNCT05444140
A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk
A Theory-guided Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk to Improve Health Promoting Behaviours: a Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 40 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.
Detailed description
A single group pretest-posttest feasibility study was conducted. The health coaching programme included four monthly health coaching sessions for three months. Feasibility of the study was measured by eligibility rate, enrollment rate, adherence rate, and attrition rate. Intervention acceptability was measured by satisfactory survey after completion of health coaching intervention. Feasibility of outcome measures was measured by the completion of outcome measures assessment at baseline and 6 months after enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Health coaching | The health coaching programme includes four monthly health coaching sessions for three months. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-11-13
- Completion
- 2021-11-13
- First posted
- 2022-07-05
- Last updated
- 2022-07-05
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05444140. Inclusion in this directory is not an endorsement.